Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falk W Lohoff

Showing results (31-40 of 134) with videos related to

Pageof 14
Sort By:
Journal of Clinical Psychopharmacology|June 4, 2010
Ziprasidone treatment of refractory generalized anxiety disorder: a placebo-controlled, double-blind studyFalk W Lohoff, Bijan Etemad, Laura A Mandos, et al.
Neuroscience Letters|September 6, 2011
Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorderSneha Narasimhan, Tiffany D Aquino, Rachel Hodge, et al.
Brain Research|January 28, 2019
Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signalingFalk W Lohoff, Gregory V Carr, Bethany Brookshire, et al.
Psychiatry Research|March 16, 2012
Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorderSneha Narasimhan, Tiffany D Aquino, Pushpinder K Multani, et al.
Geroscience|April 28, 2025
Global and tissue-specific transcriptomic dysregulation in human aging: Pathways and predictive biomarkersMuhammad Arif, Andrea Lehoczki, György Haskó, et al.
Alcoholism, Clinical and Experimental Research|October 15, 2017
Dopamine Transporter Gene Methylation is Associated with Nucleus Accumbens Activation During Reward Processing in Healthy but not Alcohol-Dependent IndividualsChristine Muench, Corinde E Wiers, Carlos R Cortes, et al.
Neuroscience Letters|February 6, 2008
Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traitsFalk W Lohoff, Marion Lautenschlager, Johannes Mohr, et al.
Alcoholism, Clinical and Experimental Research|February 16, 2016
Genetic Variation in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) Gene and Alcohol Withdrawal SeverityNisha Dutta, Sarah G Helton, Melanie Schwandt, et al.
Translational Psychiatry|July 15, 2018
The major depressive disorder GWAS-supported variant rs10514299 in TMEM161B-MEF2C predicts putamen activation during reward processing in alcohol dependenceChristine Muench, Melanie Schwandt, Jeesun Jung, et al.
Plos One|February 6, 2013
COMT and ANKK1-Taq-Ia genetic polymorphisms influence visual working memoryMarian E Berryhill, Martin Wiener, Jaclyn A Stephens, et al.
Pageof 14

Showing results (31-40 of 134) with videos related to

Sort By:
Pageof 14
Journal of Clinical Psychopharmacology|June 4, 2010
Ziprasidone treatment of refractory generalized anxiety disorder: a placebo-controlled, double-blind studyFalk W Lohoff, Bijan Etemad, Laura A Mandos, et al.
Neuroscience Letters|September 6, 2011
Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorderSneha Narasimhan, Tiffany D Aquino, Rachel Hodge, et al.
Brain Research|January 28, 2019
Deletion of the vesicular monoamine transporter 1 (vmat1/slc18a1) gene affects dopamine signalingFalk W Lohoff, Gregory V Carr, Bethany Brookshire, et al.
Psychiatry Research|March 16, 2012
Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorderSneha Narasimhan, Tiffany D Aquino, Pushpinder K Multani, et al.
Geroscience|April 28, 2025
Global and tissue-specific transcriptomic dysregulation in human aging: Pathways and predictive biomarkersMuhammad Arif, Andrea Lehoczki, György Haskó, et al.
Alcoholism, Clinical and Experimental Research|October 15, 2017
Dopamine Transporter Gene Methylation is Associated with Nucleus Accumbens Activation During Reward Processing in Healthy but not Alcohol-Dependent IndividualsChristine Muench, Corinde E Wiers, Carlos R Cortes, et al.
Neuroscience Letters|February 6, 2008
Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traitsFalk W Lohoff, Marion Lautenschlager, Johannes Mohr, et al.
Alcoholism, Clinical and Experimental Research|February 16, 2016
Genetic Variation in the Vesicular Monoamine Transporter 1 (VMAT1/SLC18A1) Gene and Alcohol Withdrawal SeverityNisha Dutta, Sarah G Helton, Melanie Schwandt, et al.
Translational Psychiatry|July 15, 2018
The major depressive disorder GWAS-supported variant rs10514299 in TMEM161B-MEF2C predicts putamen activation during reward processing in alcohol dependenceChristine Muench, Melanie Schwandt, Jeesun Jung, et al.
Plos One|February 6, 2013
COMT and ANKK1-Taq-Ia genetic polymorphisms influence visual working memoryMarian E Berryhill, Martin Wiener, Jaclyn A Stephens, et al.
Pageof 14